Ginkgolides — Hermetica Encyclopedia
Named Bioactive Compounds · Compound

Ginkgolides

Moderate Evidencediterpenoid5 PubMed Studies

Hermetica Superfood Encyclopedia

The Short Answer

Ginkgolides are diterpene lactones extracted from Ginkgo biloba leaves that act as platelet-activating factor (PAF) antagonists. These compounds theoretically modulate inflammatory responses and blood circulation through PAF receptor blockade.

5
PubMed Studies
0
Validated Benefits
Synergy Pairings
At a Glance
CategoryNamed Bioactive Compounds
GroupCompound
Evidence LevelModerate
Primary Keywordginkgolides benefits
Synergy Pairings3
Ginkgolides close-up macro showing natural texture and detail — rich in neuroprotective, antiplatelet, vasodilator
Ginkgolides — botanical close-up

Health Benefits

Origin & History

Ginkgolides growing in China — natural habitat
Natural habitat

Ginkgolides are a group of terpene trilactones primarily isolated from the leaves of the Ginkgo biloba tree, native to China. They are produced using extraction methods involving aqueous or ethanolic extraction and purification techniques to achieve high purity levels.

The research does not provide specific traditional or historical use details for ginkgolides, although Ginkgo biloba has been used in traditional medicine for centuries.Traditional Medicine

Scientific Research

There are no available clinical trials or meta-analyses on ginkgolides, as no PubMed PMIDs or relevant studies were found in the research.

Preparation & Dosage

Ginkgolides traditionally prepared — pairs with Ginkgo biloba, bilobalide, flavonoids
Traditional preparation

No clinically studied dosage ranges for ginkgolides have been reported in the research. Consult a healthcare provider before starting any new supplement.

Nutritional Profile

Ginkgolides are a class of highly specialized terpenoid lactone compounds (diterpene trilactones) isolated primarily from Ginkgo biloba leaves, root bark, and seeds. They are not macronutrients or micronutrients in the conventional dietary sense but are classified as bioactive phytochemicals. The primary members include: Ginkgolide A (C20H24O9, MW 408.4 g/mol), Ginkgolide B (C20H24O10, MW 424.4 g/mol), Ginkgolide C (C20H24O11, MW 440.4 g/mol), Ginkgolide J (C20H24O10, MW 424.4 g/mol), and Ginkgolide M (C20H24O11, MW 440.4 g/mol). In standardized Ginkgo biloba leaf extracts (e.g., EGb 761), ginkgolides typically constitute approximately 2.8–3.4% of the total extract by dry weight, with ginkgolide B being the most pharmacologically studied at concentrations of roughly 0.8–1.2% of standardized extract. Raw dried Ginkgo biloba leaves contain ginkgolides at approximately 0.03–0.18% by dry weight. These compounds contain no caloric value, no protein, no fiber, no conventional vitamins, and no dietary minerals. Bioavailability: Oral bioavailability of ginkgolide B in humans is estimated at approximately 80%, with peak plasma concentrations reached within 1–2 hours post-ingestion of standardized extract; ginkgolide A shows similar absorption. They are metabolized hepatically with a half-life of approximately 4–6 hours. Ginkgolides are notable for their unique cage-like molecular structure containing a tert-butyl group and multiple lactone rings, making them structurally distinct from all other known natural compounds.

How It Works

Mechanism of Action

Ginkgolides function as selective antagonists of platelet-activating factor (PAF) receptors, particularly blocking PAF-induced platelet aggregation and inflammatory cascades. The compounds ginkgolide A, B, and C bind competitively to PAF receptors on platelets, neutrophils, and endothelial cells. This mechanism theoretically reduces inflammatory mediator release and modulates vascular permeability.

Clinical Evidence

No human clinical trials have specifically investigated isolated ginkgolides as therapeutic agents. While ginkgolides are present in standardized Ginkgo biloba extracts used in studies, their individual contributions to observed effects remain unestablished. Most research has focused on whole Ginkgo extracts containing 6% terpene lactones (including ginkgolides) rather than isolated compounds. The absence of dedicated ginkgolide studies limits evidence-based health benefit claims.

Safety & Interactions

Safety data for isolated ginkgolides is limited due to lack of human studies. As components of Ginkgo biloba, ginkgolides may theoretically increase bleeding risk when combined with anticoagulant medications due to their anti-platelet effects. Potential interactions with blood thinners like warfarin, aspirin, or clopidogrel warrant caution. Pregnancy and breastfeeding safety is unknown for isolated ginkgolides.

Synergy Stack

Hermetica Formulation Heuristic

Frequently Asked Questions

What are the main types of ginkgolides?
The primary ginkgolides are ginkgolide A, B, C, and bilobalide. Ginkgolide B is considered the most potent PAF antagonist, while bilobalide is technically a sesquiterpene rather than a true ginkgolide.
How much ginkgolides are in Ginkgo biloba supplements?
Standardized Ginkgo biloba extracts typically contain 6% terpene lactones, which includes ginkgolides A, B, C and bilobalide. In a 120mg extract dose, this provides approximately 7.2mg of total ginkgolides.
Do ginkgolides improve memory or cognitive function?
No clinical studies have tested isolated ginkgolides for cognitive benefits. While some Ginkgo biloba extract studies show mixed results for memory, the specific contribution of ginkgolides versus other compounds remains unknown.
Can ginkgolides cause bleeding problems?
Ginkgolides theoretically may increase bleeding risk due to their anti-platelet effects, but specific bleeding data for isolated ginkgolides is unavailable. This concern is based on their mechanism as PAF receptor antagonists.
Are ginkgolides the same as Ginkgo biloba extract?
No, ginkgolides are specific diterpene compounds within Ginkgo biloba extract. The complete extract also contains flavonoid glycosides (24%) and other compounds, while ginkgolides represent only part of the 6% terpene lactone fraction.
What is the difference between ginkgolides and bilobalide in Ginkgo biloba supplements?
Ginkgolides and bilobalide are both terpene lactones found in Ginkgo biloba, but they are distinct compounds with different chemical structures. Ginkgolides are a group of compounds (including types A, B, C, J, and M), while bilobalide is a single compound. Most Ginkgo biloba extracts are standardized to contain both ginkgolides and bilobalide together, as they are believed to work synergistically, though ginkgolides are often listed separately in supplement labeling.
Are ginkgolides safe to take with blood thinners or anticoagulant medications?
Ginkgolides, particularly ginkgolide B, have been shown in laboratory studies to have platelet-activating factor (PAF) antagonist properties, which theoretically could increase bleeding risk when combined with anticoagulants like warfarin or aspirin. If you are taking blood-thinning medications, consult your healthcare provider before supplementing with Ginkgo biloba products containing ginkgolides. The clinical significance of this interaction remains uncertain, but caution is warranted.
How are ginkgolides extracted and concentrated in commercial supplements?
Ginkgolides are typically extracted from Ginkgo biloba leaves using solvent-based methods, often with ethanol or acetone, and then standardized to specific concentrations (commonly 24% ginkgo flavone glycosides and 6% terpene lactones including ginkgolides). The extraction process determines the final potency and ratio of ginkgolides to other compounds in the supplement. Different manufacturers may use different extraction techniques, which can affect the bioavailability and composition of ginkgolides in the final product.

Explore the Full Encyclopedia

7,400+ ingredients researched, verified, and formulated for optimal synergy.

Browse Ingredients
These statements have not been evaluated by the Food and Drug Administration. This content is for informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease.